Press Releases
Bolt Biotherapeutics Expands Board of Directors with Appointment of Kathleen LaPorte
Read MoreBolt Biotherapeutics Presents Ongoing Clinical Trial Poster at San Antonio Breast Cancer Symposium 2020 Virtual Meeting Read More
Data Published in Nature Cancer Highlight Preclinical Proof of Concept of Bolt Biotherapeutics’ Boltbody™ ISAC Platform Read More
Bolt Biotherapeutics Presents BDC-1001 Ongoing Clinical Trial Design and Supportive Preclinical Data at Society for Immunotherapy of Cancer Annual Meeting Read More
Bolt Biotherapeutics Closes $93.5 Million Series C Financing Read More
Bolt Biotherapeutics Announces Issuance of U.S. Patent for the Boltbody™ ISAC Technology and its Lead Development Candidate, BDC-1001 Read More
Bolt Biotherapeutics Appoints William P. Quinn as Chief Financial Officer Read More
Bolt Biotherapeutics Appoints Edith Perez, M.D., as Chief Medical Officer Read More